Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

SCORE performance in Central and Eastern Europe and former Soviet Union: MONICA and HAPIEE results

O. Vikhireva, A. Pajak, G. Broda, S. Malyutina, A. Tamosiunas, R. Kubinova, G. Simonova, Z. Skodova, M. Bobak, H. Pikhart,

. 2014 ; 35 (9) : 571-577. [pub] 20130620

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20014841

Grantová podpora
064947/Z/01/Z Wellcome Trust - United Kingdom
081081/Z/06/Z Wellcome Trust - United Kingdom
1R01 AG23522 NIA NIH HHS - United States

AIMS: The Systematic COronary Risk Evaluation (SCORE) scale assesses 10 year risk of fatal atherosclerotic cardiovascular disease (CVD), based on conventional risk factors. The high-risk SCORE version is recommended for Central and Eastern Europe and former Soviet Union (CEE/FSU), but its performance has never been systematically assessed in the region. We evaluated SCORE performance in two sets of population-based CEE/FSU cohorts. METHODS AND RESULTS: The cohorts based on the World Health Organization MONitoring of trends and determinants in CArdiovascular disease (MONICA) surveys in the Czech Republic, Poland (Warsaw and Tarnobrzeg), Lithuania (Kaunas), and Russia (Novosibirsk) were followed from the mid-1980s. The Health, Alcohol, and Psychosocial factors in Eastern Europe (HAPIEE) study follows Czech, Polish (Krakow), and Russian (Novosibirsk) cohorts from 2002-05. In Cox regression analyses, the high-risk SCORE ≥5% at baseline significantly predicted CVD mortality in both MONICA [n = 15 027; hazard ratios (HR), 1.7-6.3] and HAPIEE (n = 20 517; HR, 2.6-10.5) samples. While SCORE calibration was good in most MONICA samples (predicted and observed mortality were close), the risk was underestimated in Russia. In HAPIEE, the high-risk SCORE overpredicted the estimated 10 year mortality for Czech and Polish samples and adequately predicted it for Russia. SCORE discrimination was satisfactory in both MONICA and HAPIEE. CONCLUSION: The high-risk SCORE underestimated the fatal CVD risk in Russian MONICA but performed well in most MONICA samples and Russian HAPIEE. This SCORE version might overestimate the risk in contemporary Czech and Polish populations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20014841
003      
CZ-PrNML
005      
20200929121049.0
007      
ta
008      
200922s2014 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/eurheartj/eht189 $2 doi
035    __
$a (PubMed)23786858
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Vikhireva, Olga $u Epidemiology and Public Health Department, University College London, 1-19 Torrington Place, London WC1E 6BT, UK.
245    10
$a SCORE performance in Central and Eastern Europe and former Soviet Union: MONICA and HAPIEE results / $c O. Vikhireva, A. Pajak, G. Broda, S. Malyutina, A. Tamosiunas, R. Kubinova, G. Simonova, Z. Skodova, M. Bobak, H. Pikhart,
520    9_
$a AIMS: The Systematic COronary Risk Evaluation (SCORE) scale assesses 10 year risk of fatal atherosclerotic cardiovascular disease (CVD), based on conventional risk factors. The high-risk SCORE version is recommended for Central and Eastern Europe and former Soviet Union (CEE/FSU), but its performance has never been systematically assessed in the region. We evaluated SCORE performance in two sets of population-based CEE/FSU cohorts. METHODS AND RESULTS: The cohorts based on the World Health Organization MONitoring of trends and determinants in CArdiovascular disease (MONICA) surveys in the Czech Republic, Poland (Warsaw and Tarnobrzeg), Lithuania (Kaunas), and Russia (Novosibirsk) were followed from the mid-1980s. The Health, Alcohol, and Psychosocial factors in Eastern Europe (HAPIEE) study follows Czech, Polish (Krakow), and Russian (Novosibirsk) cohorts from 2002-05. In Cox regression analyses, the high-risk SCORE ≥5% at baseline significantly predicted CVD mortality in both MONICA [n = 15 027; hazard ratios (HR), 1.7-6.3] and HAPIEE (n = 20 517; HR, 2.6-10.5) samples. While SCORE calibration was good in most MONICA samples (predicted and observed mortality were close), the risk was underestimated in Russia. In HAPIEE, the high-risk SCORE overpredicted the estimated 10 year mortality for Czech and Polish samples and adequately predicted it for Russia. SCORE discrimination was satisfactory in both MONICA and HAPIEE. CONCLUSION: The high-risk SCORE underestimated the fatal CVD risk in Russian MONICA but performed well in most MONICA samples and Russian HAPIEE. This SCORE version might overestimate the risk in contemporary Czech and Polish populations.
650    _2
$a dospělí $7 D000328
650    _2
$a věkové rozložení $7 D017677
650    _2
$a senioři $7 D000368
650    _2
$a ateroskleróza $x mortalita $7 D050197
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mortalita $x trendy $7 D009026
650    _2
$a prognóza $7 D011379
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rozložení podle pohlaví $7 D017678
651    _2
$a Česká republika $x epidemiologie $7 D018153
651    _2
$a Litva $x epidemiologie $7 D008097
651    _2
$a Polsko $x epidemiologie $7 D011044
651    _2
$a Rusko $x epidemiologie $7 D012426
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pajak, Andrzej
700    1_
$a Broda, Grazyna
700    1_
$a Malyutina, Sofia
700    1_
$a Tamosiunas, Abdonas
700    1_
$a Kubinova, Ruzena
700    1_
$a Simonova, Galina
700    1_
$a Skodova, Zdena
700    1_
$a Bobak, Martin
700    1_
$a Pikhart, Hynek
773    0_
$w MED00009622 $t European heart journal $x 1522-9645 $g Roč. 35, č. 9 (2014), s. 571-577
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23786858 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200922 $b ABA008
991    __
$a 20200929121045 $b ABA008
999    __
$a ok $b bmc $g 1567702 $s 1105001
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 35 $c 9 $d 571-577 $e 20130620 $i 1522-9645 $m European heart journal $n Eur Heart J $x MED00009622
GRA    __
$a 064947/Z/01/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a 081081/Z/06/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a 1R01 AG23522 $p NIA NIH HHS $2 United States
LZP    __
$a Pubmed-20200922

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...